(Overall limitation of issue authorisations with waiving of pre-emptive subscription rights)
The Annual General Meeting, after having read the Board of directors report, resolves to fix at EUR 240 million the maximum nominal amount of the immediate and/or future capital increases, that could be carried out by virtue of the authorizations granted by the seventeenth to eighteenth resolutions above, an amount which may include, if applicable, the nominal amount of any additional ordinary shares to be issued to protect the interests of holders of securities that give access to the share capital, in accordance with applicable laws and regulations.
The sixteenth to twenty-third resolutions are intended to provide your Company with the most appropriate means to manage its financial structure while complying with the limits set to control any dilution of shareholdings in the event of the implementation of the resolutions.
The draft resolutions concerning capital increases stipulate that, during any period of public offering on BNP Paribas shares, the Board
These resolutions concern capital increases with pre-emptive rights for existing shareholders and capital increases without pre-emptive rights for existing shareholders, with two limits:
• the total aggregate amount of share capital increases without pre-emptive rights for existing shareholders may not exceed EUR 240 million, i.e. up to 10% of the existing share capital to date (nineteenth resolution);
• the total aggregate amount of share capital increases with or without pre-emptive rights for existing shareholders may not exceed EUR 1.2 billion, i.e. up to 50% of the existing share capital to date (twenty-first resolution).
Presentation of the resolution
In order to limit the dilution resulting from the possible use of one or more authorisations to increase capital without pre-emptive rights for existing shareholders, it is also requested in the nineteenth resolution that the meeting not allow the maximum nominal overall amount of the capital increases arising immediately and/or in the future from the use of the authorisations involving the cancellation of pre-emptive rights for existing shareholders granted by the seventeenth and eighteenth resolutions, to exceed EUR 240 million (9.63% of capital at 31 December 2015) under any circumstances.